Smoking Cessation Lighter and Method
A lighter for tobacco products suppresses the urge to smoke by operant conditioning.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7063726 | Plasticized bone grafts and methods of making and using same The invention provides a plasticized bone and/or soft tissue product that does not require special conditions of storage, for example refrigeration or freezing, exhibits materials properties that approximate those properties present in natural tissue, is not brittle... | 06/20/2006 |
| 6980999 | Method and system for providing dietary information An apparatus, method and data structure for procuring, analyzing, and communicating dietary information, particularly information regarding the research, evaluation and selection of dietary products. The system provides a comprehensive combination of dietary informa... | 12/27/2005 |
| 6916910 | Method and process for the production of collagen preparations from invertebrate marine animals and compositions thereof The present invention relates to a process for the production of marine invertebrate type V telopeptide containing collagen preparations from marine invertebrates, compositions containing preparations, and methods of using these preparations. The collagen preparatio... | 07/12/2005 |
| 6902653 | Apparatus and method for photocatalytic purification and disinfection of fluids An apparatus and method for the photocatalytic conversion of contaminants in a fluid stream. Fluid is directed through a semitransparent packed bed or an open cell, three dimensionally reticulated, fluid permeable, semiconductor unit. Within the unit, a semiconducto... | 06/07/2005 |
| 6770673 | Therapeutic uses of arglabin in combination with other chemotherapy agents Compositions and kits containing a first chemotherapeutic agent that includes arglabin or a derivative thereof and a second chemotherapeutic agent are described. The compositions and kits are effective for treating cancer in a human patient. Methods for suppressing ... | 08/03/2004 |
| 6693127 | Pharmaceutical compositions of arglabin and arglabin derivatives Pharmaceutical compositions containing arglabin and arglabin derivatives are described. The compositions can be in unit dosage form and are useful for the treatment of cancer in humans.... | 02/17/2004 |
| 6429203 | Farnesyl-protein transferase inhibitors Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described... | 08/06/2002 |
| 6416995 | Bioreactor mediated recellularization of natural and tissue engineered vascular grafts The invention provides a device and process for recellularizing essentially acellular or devitalized tissue grafts, including for example essentially acellular or devitalized vascular tissue grafts, derived from human or animal sources, or as constructed ... | 07/09/2002 |
| 6301574 | System for providing business information An apparatus, method and data structure for communicating business information, including outsourcing information. Contractor provide information regarding their products and services into the system. Outsourcing companies search a database containing con... | 10/09/2001 |
| 6293301 | Backflow prevention device enclosure having improved access An apparatus for maintaining the temperature of material contained in fluid conveying devices. The apparatus may include an enclosure having an improved door, mounting bracket, locking mechanism, heating device and a secure structure for accessing the upp... | 09/25/2001 |
| 6268394 | Farnesyl-protein transferase inhibitors Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described... | 07/31/2001 |
| 6262110 | Farnesyl-protein transferase inhibitors Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting fanesyl-protein transferase activity are also described.... | 07/17/2001 |
| 6197767 | Arglabin compounds and therapeutic uses thereof The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.... | 03/06/2001 |
| 6051565 | Farnesyl-protein transferase inhibitors Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described... | 04/18/2000 |
| 6020365 | Arglabin compounds and therapeutic uses thereof The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.... | 02/01/2000 |